A Summary of peer-reviewed, published literature comparing the effectiveness of AsepticSure versus Xenex

It is of paramount importance to remember, that while there are other companies and technologies competing in our sector of business, only AsepticSure has demonstrated the ability to actually break the reinfection cycle in a healthcare setting. That is what sets us apart, as demonstrated at Belleville General Hospital in Ontario, Canada.

The demonstration at Belleville in which a ward that had averaged “one to two new MRSA infections a month” and has now gone more than a year without a new infection following a single AsepticSure disinfection, is strong evidence that when you kill 100% of the infective pathogen in a healthcare setting, you have broken the reinfection cycle. A response demonstrating this level of efficacy and effectiveness was simply not available until AsepticSure. This is the solution to a previously unsolvable problem.

We have demonstrated at our Innovation Park, Queen’s University Laboratories, that you must obtain 100% Kill to be effective. Working with MRSA, a 5-log sample was decontaminated by 3-log (99.9% kill). Set aside and simply observed, the remaining 0.1% of bacteria began to regenerate in 5 hours. In 5 days it had grown back to full strength! Only AsepticSure has demonstrated the ability to eliminate that 0.1% in both laboratory and real world hospital settings throughout an entire room!

Chart_AsepticSure_Versus_Xenex

References:

image

  1. Nerandzic MM, Thota P, Sankar TC, Jencson A, Cadnum JL, Ray AJ, Salata RA, Watkins RR, and Donskey CJ. Evaluation of a Pulsed Xenon Ultraviolet Disinfection System for Reduction of Healthcare-Associated Pathogens in Hospital Rooms. Infection Control & Hospital Epidemiology. 2015, Feb; 36:192-197.

  2. Zoutman D, Shannon M, Mandel A. Effectiveness of a novel ozone-based system for the rapid high-level disinfection of health care spaces and surfaces. American Journal of Infection Control. 2011 Dec; 39(10):873-879.

Contact:

Medizone International, Inc. (MZEI.OB)

4000 Bridgeway, Suite 401
Sausalito, CA 94965

Telephone: 415-331-0303

Email: operations@medizoneint.com

Investor Relations:

John Pentony

Investor Relations
Medizone International, Inc.

Telephone: (415) 331-0202

E: j.pentony@medizoneint.com

Media Contact:

Gary Hanauer

Media Relations
Medizone International, Inc.

Telephone: (510) 686-1238

E: GarHan@aol.com